Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Becker

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Archives of Pathology & Laboratory Medicine|September 18, 1998
A clinician's view of thrombotic disorders of the cardiovascular systemR C Becker
Cardiology|January 1, 1992
Seminars in thrombosis, thrombolysis, and vascular biology. 6. Procoagulant statesR C Becker
Clinical Cardiology|January 1, 1994
Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusionR C Becker
Cleveland Clinic Journal of Medicine|September 1, 1990
Recombinant t-PA and platelet activityR C Becker
Cardiology|January 1, 1990
Cardiovascular disease in women. Introductory article. Clinical highlights and future directionsR C Becker
Coronary Artery Disease|August 1, 1994
Toward achieving optimal reperfusion: revisiting thrombolysisR C Becker
Journal of Thrombosis and Thrombolysis|June 12, 1999
New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practiceR C Becker
Clinical Cardiology|April 1, 1994
Beta-adrenergic blockade following thrombolytic therapy: is it helpful or harmful?R C Becker
Cardiology|January 1, 1991
Seminars in thrombosis, thrombolysis and vascular biology. 3. Platelet activity in cardiovascular diseaseR C Becker
The American Journal of Cardiology|January 3, 1992
Thrombin antagonists and antiplatelet agentsR C Becker
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Archives of Pathology & Laboratory Medicine|September 18, 1998
A clinician's view of thrombotic disorders of the cardiovascular systemR C Becker
Cardiology|January 1, 1992
Seminars in thrombosis, thrombolysis, and vascular biology. 6. Procoagulant statesR C Becker
Clinical Cardiology|January 1, 1994
Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusionR C Becker
Cleveland Clinic Journal of Medicine|September 1, 1990
Recombinant t-PA and platelet activityR C Becker
Cardiology|January 1, 1990
Cardiovascular disease in women. Introductory article. Clinical highlights and future directionsR C Becker
Coronary Artery Disease|August 1, 1994
Toward achieving optimal reperfusion: revisiting thrombolysisR C Becker
Journal of Thrombosis and Thrombolysis|June 12, 1999
New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practiceR C Becker
Clinical Cardiology|April 1, 1994
Beta-adrenergic blockade following thrombolytic therapy: is it helpful or harmful?R C Becker
Cardiology|January 1, 1991
Seminars in thrombosis, thrombolysis and vascular biology. 3. Platelet activity in cardiovascular diseaseR C Becker
The American Journal of Cardiology|January 3, 1992
Thrombin antagonists and antiplatelet agentsR C Becker
Pageof 15